Altavant Sciences GmbH
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Aug 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Jan 16 to 25, 2027 · next Jan 16
- 1 fee due Mar 19, 2027The maintenance fee for Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors (US 11,759,462) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
- 1 fee due Jun 1, 2027The maintenance fee for Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors (US 9,199,994) comes due Jun 1, 2027. Unpaid by Dec 1, 2027, it lapses early.
- 1 fee due Aug 27, 2027The maintenance fee for Method for Treating Pulmonary Arterial Hypertension and Associated Pulmonary Arterial Hypertension (US 11,911,382) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,550,389 | Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors In force · USPTO record | In force | USPTO record | |
| US 9,199,994 | Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors In force · High confidence | In force | High confidence | |
| US 10,350,208 | Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors In force · High confidence | In force | High confidence | |
| US 10,660,893 | Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors In force · High confidence | In force | High confidence | |
| US 11,759,462 | Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors In force · Medium confidence | In force | Medium confidence | |
| US 10,710,948 | Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanone In force · USPTO record | In force | USPTO record | |
| US 11,708,365 | Processes for preparing TPH1 inhibitors In force · USPTO record | In force | USPTO record | |
| US 11,576,915 | Method for Treating Pulmonary Arterial Hypertension and Associated Pulmonary Arterial Hypertension and Daily Dosing In force · High confidence | In force | High confidence | |
| US 11,911,382 | Method for Treating Pulmonary Arterial Hypertension and Associated Pulmonary Arterial Hypertension In force · High confidence | In force | High confidence | |
| US 11,607,413 | Dosage Regime and Method for Treating Pulmonary Arterial Hypertension In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 2 patents in force now held by others · 9 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
12 no status recorded
Showing 1 to 10 of 12, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. No title is shown: the bulk publication record carries none for these applications, and this site holds no USPTO file history for them.
| Application | Filed | Status |
|---|---|---|
| 18/159,494 | Jan 25, 2023 | No status recorded |
| 18/149,992 | Jan 4, 2023 | No status recorded |
| 17/726,164 | Apr 21, 2022 | No status recorded |
| 17/527,448 | Nov 16, 2021 | No status recorded |
| 17/513,491 | Oct 28, 2021 | No status recorded |
| 17/507,295 | Oct 21, 2021 | No status recorded |
| 17/926,297 | May 20, 2021 | No status recorded |
| 17/759,700 | Jan 29, 2021 | No status recorded |
| 17/781,289 | Dec 2, 2020 | No status recorded |
| 16/714,260 | Dec 13, 2019 | No status recorded |
10 of 12 applications shown.
Pro members see all 12 published applications.